References
1. Jutel M, Akdis M, Akdis C. Histamine, histamine receptors and their
role in immune pathology. Clinical & Experimental Allergy.2009;39(12):1786-1800.
2. Jutel M, Watanabe T, Klunker S, et al. Histamine regulates T-cell and
antibody responses by differential expression of H1 and H2 receptors.Nature. 2001;413(6854):420-425.
3. Thompson RJ, Sayers I, Kuokkanen K, Hall IP. Purinergic Receptors in
the Airways: Potential Therapeutic Targets for Asthma? Frontiers
in allergy. 2021:16.
4. Li XX, Lee JD, Massey NL, et al. Pharmacological characterisation of
small molecule C5aR1 inhibitors in human cells reveals biased activities
for signalling and function. Biochem Pharmacol. 2020;180:114156.
5. Schneditz G, Elias JE, Pagano E, et al. GPR35 promotes glycolysis,
proliferation, and oncogenic signaling by engaging with the sodium
potassium pump. Sci Signal. 2019;12(562).
6. Kim HJ, Kim SH, Kim M, et al. Inhibition of 15-PGDH prevents ischemic
renal injury by the PGE(2)/EP(4) signaling pathway mediating
vasodilation, increased renal blood flow, and increased adenosine/A(2A)
receptors. Am J Physiol Renal Physiol. 2020;319(6):F1054-F1066.